Interactions of aminoglycosides with RNAs and proteins via carbohydrate microarray
(2.Wuxi Medical School, Jiangnan University, Wuxi, Jiangsu, China 214122)
【Abstract】Aminoglycosides are broad-spectrum antibacterials to treat bacterial infections, especially gram-negative bacteria infections. However, aminoglycosides are losing efficacy because of the increase in antibiotic resistance and their inherent toxicity, attracting more interests in developing new aminoglycosides. Several clinically used aminoglycosides are mainly exerted by inhibition of protein synthesis through binding to bacterial rRNA. The bacterial ribosome RNA is the most currently exploited RNA drug target. Identification of new compounds that target RNAs is indispensable to fight with the growing threat that bacteria pose to human safety. In this work, we used carbohydrate microarrays to probe interactions of low molecular weight ligands with RNAs and proteins. Carbohydrate microarrays, comprising hundreds to thousands of different glycan structures on surfaces in a spatially discrete pattern, are sensitive and versatile tools to study the interactions between biological macromolecules. Herein, aminoglycosides have been immobilized onto the modified glass microscope slides and their interactions with RNAs and proteins are then measured through the labeled fluorescence. The results displayed that microarray can be used to detect the binding of aminoglycosides with three types of target molecules, including the small RNA oligonucleotide mimics of aminoglycoside binding sites in the ribosome (rRNA A-site mimics), the large group Ⅰ ribozyme RNA (approximately 400 nucleotide) and certain proteins (toxicity-causing enzymes, such as DNA polymerase and phospholipase C). For rRNA A-site mimics, the fluorescence intensities of 16 S rRNA is stronger than that of 18 S rRNA, illustrating that as a screen technique, the microarray method can not only determine the binding affinity to RNA but also detect the specific binding to bacterial rRNA mimic. The ability to screen group Ⅰ ribozyme RNA can be helpful to the discovery of new RNA therapeutic targets. Binding of immobilized aminoglycosides to toxicity-causing proteins (DNA polymerase and phospholipase C) is a new method to study of aminoglycoside toxicity. These studies lay the foundation for rapid identification of new RNA-binding ligands with strong and specific binding affinity for their desired targets.
【Keywords】 aminoglycoside microarrays; rRNA A-site mimics; group Ⅰ ribozyme; klenow DNA polymerase; phospholipase C; aminoglycoside microarrays; r RNA A-site mimics; group I ribozyme; klenow DNA polymerase; phospholipase C;
Kondo S, Hotta K. Semisynthetic aminoglycoside antibiotics: development and enzymatic modifications. J Infect Chemother, 1999, 5(1): 1-9.
Magnet S, Blanchard JS. Molecular insights into aminoglycoside action and resistance. Chem Rev, 2005, 105(2): 477-498.
Ding YL, Hofstadler SA, Swayze EE, et al. Design and synthesis of paromomycin-related heterocyclesubstituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay. Angew Chem Int Ed, 2003, 42(29): 3409-3412.
Shandrick S, Zhao Q, Han Q, et al. Monitoring molecular recognition of the ribosomal decoding site. Angew Chem Int Ed, 2004, 116(24): 3239-3244.
Verhelst SHL, Michiels PJA, van der Marel GA, et al. Surface plasmon resonance evaluation of various aminoglycoside–RNA hairpin interactions reveals low degree of selectivity. Chem Bio Chem, 2004, 5(7): 937-942.
Wang DN. Carbohydrate microarrays. Proteomics, 2003, 3(11): 2167-2175.
Horlacher T, Seeberger PH. Carbohydrate arrays as tools for research and diagnostics. Chem Soc Rev, 2008, 37(7): 1414-1422.
Park S, Gildersleeve JC, Blixt O, et al. Carbohydrate microarrays. Chem Soc Rev, 2013, 42(10): 4310-4326.
Yang J, Moraillon A, Siriwardena A, et al. Carbohydrate microarray for the detection of glycan-protein interactions using metal-enhanced fluorescence. Anal Chem, 2015, 87(7): 3721-3728.
Childs RA, Palma AS, Wharton S, et al. Receptor-binding specificity of pandemic influenza A(H1N1)2009 virus determined by carbohydrate microarray. Nat Biotechnol, 2009, 27(9): 797-799.
Rogers CJ, Clark PM, Tully SE, et al. Elucidating glycosaminoglycan-protein-protein interactions using carbohydrate microarray and computational approaches. Proc Natl Acad Sci USA, 2011, 108(24): 9747-9752.
Mendell JT, Olson EN. Micro RNAs in stress signaling and human disease. Cell, 2012, 148(6): 1172-1187.
Wong SC, Klein JJ, Hamilton HL, et al. Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the efficacy of cholesterol-conjugated small interfering RNAs in vivo. Nucleic Acid Ther, 2012, 22(6): 380-390.
Piñeiro D, Martinez-Salas E. RNA structural elements of hepatitis C virus controlling viral RNA translation and the implications for viral pathogenesis. Viruses, 2012, 4(10): 2233-2250.
Disney MD, Magnet S, Blanchard JS, et al. Aminoglycoside microarrays to study antibiotic resistance. Angew Chem Int Ed, 2004, 43(12): 1591-1594.
Mingeot-Leclercq MP, Brasseur R, Schanck A. Molecular parameters involved in aminoglycoside nephrotoxicity. J Toxicol Environ Health, 1995, 44(3): 263-300.
Ren YG, Martínez J, Kirsebom LA, et al. Inhibition of klenow DNA polymerase and poly(A)-specific ribonuclease by aminoglycosides. RNA, 2002, 8(11): 1393-1400.
Morris JC, Lei PS, Zhai HX, et al. Phosphatidylinositol phospholipase C is activated allosterically by the aminoglycoside G418. J Biol Chem, 1996, 271(26): 15468-15477.
Dal Pozzo A, Vanini L, Fagnoni M, et al. Preparation and characterization of poly(ethylene glycol)-crosslinked reacetylated chitosans. Carbohydr Polym, 2000, 42(2): 201-206.
Muthusamy S, Gnanaprakasam B, Suresh E. Desymmetrization of cyclic anhydrides using dihydroxy compounds: selective synthesis of macrocyclic tetralactones. Org Lett, 2006, 8(9): 1913-1916.
Disney MD, Haidaris CG, Turner DH. Recognition elements for 5′exon substrate binding to the Candida albicans group Ⅰ intron. Biochemistry, 2001, 40(21): 6507-6519.
Wong CH, Hendrix M, Priestley ES, et al. Specificity of aminoglycoside antibiotics for the A-site of the decoding region of ribosomal RNA. Chem Biol, 1998, 5(7): 397-406.
Wong CH, Hendrix M, Manning DD, et al. A library approach to the discovery of small molecules that recognize RNA: use of a 1, 3-hydroxyamine motif as core. J Am Chem Soc, 1998, 120(33): 8319-8327.
Battaglia C, Salani G, Consolandi C, et al. Analysis of DNA microarrays by non-destructive fluorescent staining using SYBR green II. Biotechniques, 2000, 29(1): 78-81.
Disney MD, Seeberger PH. Aminoglycoside microarrays to explore interactions of antibiotics with RNAs and proteins. Chem A Eur J, 2004, 10(13): 3308-3314.
Griffey RH, Hofstadler SA, Sannes-Lowery KA, et al. Determinants of aminoglycoside-binding specificity for r RNA by using mass spectrometry. Proc Natl Acad Sci USA, 1999, 96(18): 10129-10133.
Ryu, DH, Rando RR. Aminoglycoside binding to human and bacterial A-site r RNA decoding region constructs. Bioorg Med Chem, 2001, 9(10): 2601-2608.
Llano-Sotelo B, Azucena EF, Kotra LP, et al. Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-t RNA site. Chem Biol, 2002, 9(4): 455-463.
Mei HY, Mack DP, Galan AA, et al. Discovery of selective, small-molecule inhibitors of RNA complexes-1. The tat protein/TAR RNA complexes required for HIV-1 transcription. Bioorg Med Chem, 1997, 5(6): 1173-1184.
Otto GA, Puglisi JD. The pathway of HCV IRES-mediated translation initiation. Cell, 2004, 119(3): 369-380.
Michael K, Wang H, Tor Y. Enhanced RNA binding of dimerized aminoglycosides. Bioorg Med Chem, 1999, 7(7): 1361-1371.
Velagapudi SP, Seedhouse SJ, Disney MD. Structure-activity relationships through sequencing(St ARTS)defines optimal and suboptimal RNA motif targets for small molecules. Angew Chem Int Ed, 2010, 49(22): 3816-3818.
Mikkelsen NE, Johansson K, Virtanen A, et al. Aminoglycoside binding displaces a divalent metal ion in a t RNA-neomycin B complex. Nat Struct Biol, 2001, 8(6): 510-514.
Mingeot-Leclercq M-P, Tulkens PM. Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother, 1999, 43(5): 1003-1012.